Heart Rate Variability Biofeedback for Substance Use Disorder: Health Policy Implications
Policy Insights from the Behavioral and Brain Sciences · 2022-10 · 9 (2) · 156-163
DOI: 10.1177/23727322221113037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Policy Insights from the Behavioral and Brain Sciences, online erschienen am 10.09.2022. Verfasst von Sarah T Wieman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Suffolk University, Boston, MA, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIDA NIH HHS, National Institute of Drug Abuse.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Substance use disorder (SUD) exacts massive individual and public health burdens, in part because of its relapsing nature. First-line SUD treatments aim to strengthen affective and cognitive control to help individuals override impulses to use alcohol and other drugs, yet automatic physiological processes compromised by SUD interact with affective states and the environment, compromising effortful cognitive control and undermining attempts to avoid substance use. While existing first-line SUD treatments may indirectly help offset these vulnerabilities, none target them. Heart rate variability biofeedback (HRVB) involves rhythmic breathing that directly targets these deficits, complementing first-line SUD treatments. HRVB has evolved from a clinic-based treatment to an ambulatory intervention utilizing wearable biosensors and smartphone applications with capacity for just-in-time support of affective and behavioral self-regulation. There is evidence supporting the efficacy of HRVB for SUD, but more research is needed to fully assess HRVB's potential to support SUD recovery and inform policy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, Suffolk University, Boston, MA, USA.
- Recovery Research Institute, Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA, USA.
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: David Eddie
Förderung
- NIAAA NIH HHS
- NIDA NIH HHS
- National Institute of Drug Abuse
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Wieman, S. T., & Eddie, D. (2022). Heart Rate Variability Biofeedback for Substance Use Disorder: Health Policy Implications. Policy Insights from the Behavioral and Brain Sciences, 9(2), 156-163. https://doi.org/10.1177/23727322221113037
Vancouver
Wieman ST, Eddie D. Heart Rate Variability Biofeedback for Substance Use Disorder: Health Policy Implications. Policy Insights from the Behavioral and Brain Sciences. 2022;9(2):156-163. doi:10.1177/23727322221113037
BibTeX
@article{Wieman2022,
author = {Wieman, Sarah T and Eddie, David},
title = {Heart Rate Variability Biofeedback for Substance Use Disorder: Health Policy Implications},
journal = {Policy Insights from the Behavioral and Brain Sciences},
year = {2022},
volume = {9},
number = {2},
pages = {156--163},
doi = {10.1177/23727322221113037}
}
EUVIMED